反応と合成の進歩シンポジウム 発表要旨概要
第31回反応と合成の進歩シンポジウム
セッションID: 1P-37
会議情報

[L-Arg, L/D-3-(2-naphthyl)alanine]―タイプ(E)―アルケン型ジペプチドイソスターの立体選択的合成とケモカイン受容体CXCR4アンタゴニストFC131のペプチド
*玉村 啓和平松 健一上田  聡Zixuan WangJohn O. TrentStephen C. Peiper山本 直樹中島 秀喜大高  章藤井 信孝
著者情報
会議録・要旨集 フリー

詳細
抄録

L,L- And L,D-type (E)-alkene dipeptide isosteres (EADIs), which have unnatural side chains at the α-position, were synthesized by the combination of stereoselective aziridinyl ring-opening reactions and organozinc-copper-mediated anti-SN2'reactions to a single substrate of γ,δ-cis-γ,δ-epimino (E)-α,β-enoate. The utility of this procedure was demonstrated by the stereo-controlled synthesis of a couple of diastereomeric EADIs of Arg-L/D-3-(2-naphthyl)alanine (Nal) that is contained in a low molecular weight CXCR4 antagonist FC131 [cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)]. Several FC131 analogs, in which these EADIs were inserted for reduction of their peptide character, were synthesized for the development of nonpeptide CXCR4 antagonists with anti-HIV and anti-cancer-metastasis activity.

fig.1 Fullsize Image
著者関連情報
© 2005 日本薬学会
前の記事 次の記事
feedback
Top